DuPont de Nemours, Inc. is currently trading at a trailing price-to-earnings ratio of 61.15, a premium figure that looks vastly different when set against its forward P/E of 17.91. This stark compression in valuation multiples is the central pillar supporting the current consensus target gap on Wall Street. With the stock priced at $142.47, analysts see a clear path toward a mean target price of $169.8126, translating to a 19.2% implied upside.
* A cohort of 16 analysts maintains a consensus buy recommendation on the stock. * Target price adjustments are highly active, featuring a mix of upward nudges and cautious trims from major firms this month. * Insiders have focused exclusively on liquidating positions, recording six meaningful sales totaling 95,584 shares.
DD in focus
The wide chasm between DuPont's trailing valuation and its forward earnings expectations indicates that the market is pricing in a significant operational turnaround or cyclical recovery. At a trailing P/E of 61.15, the stock appears expensive on historical earnings. However, the drop to a forward P/E of 17.91 suggests that Wall Street expects earnings to catch up rapidly over the next fiscal year. This anticipated earnings growth is what makes the 19.2% upside target realistic to the 16 analysts covering the name.
Looking at the data-as-of timestamp of August 7, 2026, at 23:38:00 UTC (2026-08-07T23:38:00.074Z), we can observe a dynamic tug-of-war among major investment banks regarding DuPont's valuation ceiling. On August 7, RBC Capital adjusted its target downward, lowering it from $180 to $176. This minor trim followed a more optimistic revision from UBS on August 5, which raised its target to $178 from $175. Earlier in the quarter, on July 2, Citigroup also showed confidence by boosting its target to $170 from $168. These shifting numbers show that while the absolute top-end expectations are being dialed back slightly by some, the baseline target remains firmly above the current $142.47 trading level.
This upward consensus comes despite a total absence of insider buying. Over the recent period, there were six meaningful insider sales, resulting in 95,584 shares being liquidated. While insider selling can sometimes trigger caution, it often reflects personal portfolio diversification rather than a lack of faith in the company's prospects, especially when institutional analysts remain overwhelmingly positive. Investors looking at the stock also have a dividend yield of 1.67% to consider, which offers a steady stream of passive income, while a beta of 1.09 indicates that the stock moves almost in lockstep with the broader market, avoiding excessive volatility. The next major catalyst for the stock will likely be its upcoming earnings release scheduled for November 5, 2026.
Peer lens
How does DuPont compare to its peers within the materials sector? The average upside for the sector stands at 15.5%, meaning DuPont’s 19.2% expected appreciation puts it ahead of the pack, securing the 8th rank in its peer group. This premium positioning is visible on the DuPont de Nemours, Inc. stock analysis page, which tracks these shifting dynamics in real time.
However, if you look deeper into the sector, several names offer even wider target gaps. Celanese Corporation (CE) is currently looking at a substantial 45.4% implied upside, highlighting a much more depressed current valuation or a highly aggressive growth outlook from analysts. Similarly, Albemarle (ALB) shows a 38.3% target gap, driven by the volatile swings in its underlying commodity markets. FMC Corporation (FMC) also outpaces DuPont with a 29.7% implied upside.
What this tells us is that while DuPont is outperforming the sector average of 15.5%, it is not the most aggressive play in the space. Instead, DuPont represents a middle-ground option: more upside potential than the average materials stock, but with less of the extreme valuation gaps seen in peers like Celanese or Albemarle. For investors tracking the sector, this balance of a 19.2% target gap and a reasonable forward P/E of 17.91 presents a compelling case of steady, calculated expectation rather than speculative hope.